Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Elderly

Study comparing two regimens of nab-paclitaxel and carboplatin combination in elderly subject (≥ 70 years old) with advanced NSCLC

See detailed information including eligibility.

 
06/2014
07/2017
NCT02151149
Cancer